GlassScriptPhysician profile
Olga S Jones
NPI 1265657571
$7,423.73
in general payments reported to CMS, 2019-2025
34 companies · $876 in 2025
The $876 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,264 · 2020: $672 · 2021: $1,454 · 2022: $1,230 · 2023: $978 · 2024: $950 · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,784 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,783.65 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,404.85 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $919.73 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $829.68 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $812.46 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $691.08 | 2019-2025 | Jardiance |
| Abbott Laboratories | $367.33 | 2021-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $326.81 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $301.60 | 2019-2023 | Belsomra, Segluromet, Steglatro |
| Janssen Pharmaceuticals, INC | $289.56 | 2019-2022 | |
| Glaxosmithkline, LLC. | $283.95 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Pfizer INC. | $262.89 | 2019-2025 | |
| Amgen INC. | $184.99 | 2019-2025 | Otezla, Repatha, Repatha |
| Astellas Pharma US INC | $146.95 | 2019-2024 | Veozah |
| Abbvie INC. | $83.37 | 2021-2025 | |
| Genentech USA, INC. | $67.05 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $66.56 | 2019-2023 | |
| Dexcom, INC. | $52.98 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $42.74 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $33.90 | 2020-2021 | |
| Vbi Vaccine (Delaware) INC. | $27.38 | 2022 | |
| Exact Sciences Corporation | $27.15 | 2023-2024 | Cologuard Collection Kit |
| Corcept Therapeutics | $22.87 | 2021 | |
| Ironwood Pharmaceuticals, INC | $22.33 | 2020 | |
| Biogen, INC. | $21.04 | 2021 | |
| Redhill Biopharma INC. | $15.51 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.33 | 2020 | |
| Therapeuticsmd, INC. | $14.32 | 2019 | |
| Shire North American Group INC | $14.07 | 2019 | |
| Ibsa Pharma INC. | $13.64 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.50 | 2019 | |
| Allergan, INC. | $12.55 | 2020 | |
| Dynavax Technologies Corporation | $12.11 | 2019 | |
| Vistapharm, INC. | $11.81 | 2021 | |
| Sanofi Pasteur INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.